Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
Lucy E. Horton
1, Robert W. Cross
1, Jessica N. Hartnett, Emily J. Engel, Saori Sakabe, Augustine Goba, Mambu Momoh, John Demby Sandi, Thomas W. Geisbert, Robert F. Garry, John S. Schieffelin, Donald S. Grant, and Brian M. Sullivan
Author affiliations: The Scripps Research Institute, La Jolla, California, USA (L.E. Horton, S. Sakabe, B.M. Sullivan); University of Texas Medical Brach, Galveston, Texas, USA (R.W. Cross, T.W. Geisbert); Tulane University School of Medicine, New Orleans, Louisiana, USA (J.N. Hartnett, E.J. Engel, R.F. Garry, J.S. Schieffelin); Kenema Government Hospital, Kenema, Sierra Leone (A. Goba, M. Momoh, J.D. Sandi, D.S. Grant); Ministry of Health and Sanitation, Freetown, Sierra Leone (A. Goba, M. Momoh, J.D. Sandi); Eastern Polytechnic Institute, Kenema (M. Momoh, D.S. Grant); Njala University, Moyamba, Sierra Leone (J.D. Sandi); University of Sierra Leone, Freetown (D.S. Grant)
Main Article
Figure 1
Figure 1. Clinical features suggestive of vascular permeability in patients with Lassa fever, Sierra Leone, 2015–2018. Patients with acute LF who had >2 signs or symptoms indicating vascular permeability at the time of admission were more likely to have fatal outcomes based on multiple logistic regression compared with patients who had no of symptoms vascular permeability (p = 0.0335). Case-fatality rates associated with various signs and symptoms are shown at the top and violin plot depicting the number of persons in each category at the bottom (median value indicated by dotted vertical lines). CFR, case-fatality rate; E, generalized edema; MB, mucosal membrane bleeding; RS, respiratory symptoms, such as cough or pulmonary edema.
Main Article
Page created: September 09, 2020
Page updated: October 17, 2020
Page reviewed: October 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.